Loading news...
Covalis (Gibraltar) Ltd initiated a new position in Core Scientific, buying 2,080,550 shares in the fourth quarter. The quarter-end position value increased by $30.29 million due to the new purchase.
Core Scientific, Inc. (NASDAQ: CORZZ - Get Free Report)'s share price shot up 7.8% during mid-day trading on Wednesday. The stock traded as high as $16.54 and last traded at $16.54. 2,979 shares changed hands during trading, a decline of 77% from the average session volume of 13,051 shares. The stock had previously closed at
AUSTIN, Texas & INDIANAPOLIS & SILVERSTONE, England--(BUSINESS WIRE)---- $CORZ--Core Scientific, Inc. (NASDAQ: CORZ) (“Core Scientific” or the “Company”), a leader in digital infrastructure for high-density colocation, and Cadillac Formula 1® Team have announced a multi-year global partnership, naming Core Scientific as the team's Official Data Center Partner. Core Scientific will play a central role in advising and shaping the team's data center infrastructure in its new U.S. headquarters, currently und.
AUSTIN, Texas--(BUSINESS WIRE)--Core Scientific, Inc. (Nasdaq: CORZ) (“Core Scientific” or the “Company”), a leader in digital infrastructure for high-density colocation, today announced that it completed the initial closing of a $500 million 364-day loan facility (the “Facility”) provided by Morgan Stanley. The Facility includes an accordion feature that provides the potential to increase total commitments by up to an additional $500 million, for total commitments of up to $1.0 billion, subjec.
Clearline Capital LP bought 3,436,127 shares of Core Scientific; estimated transaction value $59.91 million (based on average price for the quarter) Quarter-end position value increased $45.79 million, reflecting both trading and price appreciation Trade size represented 2.96% of 13F AUM Post-trade holding: 4,689,443 shares, valued at $68.28 million The position now accounts for 3.37% of reportable AUM, placing it outside the fund's top five holdings
CORZ is positioned for significant margin expansion and top-line growth from FQ1'26 onwards, based on the guidance of ~$850M annual revenue and 75–80% gross margins from CRWV contracts. Despite the cooling AI sentiment, the capex-light model and strong industry tailwinds support the Bitcoin miner turned HPC provider's growth prospects. CORZ's growth-to-valuation profile is attractive post-correction, with FY2026 EV/Sales at 7.91x and projected 3Y revenue growth CAGR of +62.9% outpacing most peers.
Core Scientific's NASDAQ: CORZ stock price struggles with traction in early 2026, but don't be fooled. The company's strategic shift from Bitcoin mining to AI mining is gaining traction and accelerating, and it is on track for robust, profitable growth in the coming years.
Core Scientific (NASDAQ: CORZ) executives used the company's fiscal fourth-quarter 2025 earnings call to emphasize progress in building out large-scale AI and high-performance computing (HPC) infrastructure while continuing to rely on Bitcoin mining as the primary revenue source during the transition. Quarry and CoreWeave buildout: energized capacity rising, billing ramp underway Chief Executive Officer Adam Sullivan
Iran crypto withdrawals spike amid U.S., Israel military operation. These miners tumble on plans to sell bitcoin holdings.
Core Scientific, Inc. (CORZ) Q4 2025 Earnings Call Transcript
Although the revenue and EPS for Core Scientific, Inc. (CORZ) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Core Scientific, Inc. (CORZ) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.01 per share a year ago.
AUSTIN, Texas--(BUSINESS WIRE)--Core Scientific, Inc. (NASDAQ: CORZ), a leader in digital infrastructure for high-density colocation services, today announced financial results for the fourth quarter of 2025. “We're now past the halfway point on our existing builds and scaling our colocation platform into a 1.5 gigawatt pipeline of leasable capacity,” said Adam Sullivan, Chief Executive Officer of Core Scientific. “With a multi-geography footprint and proven execution, we're accelerating RFS ti.
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
AUSTIN, Texas--(BUSINESS WIRE)--Core Scientific, Inc. (Nasdaq: CORZ) (“Core Scientific” or the “Company”), a leader in digital infrastructure for high-density colocation, today announced it will release its fourth quarter and fiscal year 2025 financial results after the financial markets close on Monday, March 2, 2026. Management will host a conference call and live audio webcast to discuss the results at 3:30 p.m. Central Time. Hosting the call and webcast to review results for the fourth quar.
CenterBook Partners LP decreased its position in shares of Core Scientific, Inc. (NASDAQ: CORZ) by 83.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 57,404 shares of the company's stock after selling 299,966 shares during the period. CenterBook Partners LP's holdings
BIT Capital GmbH trimmed its position in Core Scientific, Inc. (NASDAQ: CORZ) by 47.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 250,353 shares of the company's stock after selling 224,864 shares during the period. BIT Capital
Oasis Management initiated a 2,643,729-share stake in Core Scientific during the fourth quarter. The quarter-end position value increased by $38.49 million due to the new purchase.
Helix Partners Management increased its Core Scientific stake by 350,000 shares in the fourth quarter; the estimated trade value was $6.10 million based on average fourth-quarter pricing. Despite the buy, the Core Scientific position's reported value fell by $12.65 million in the quarter, reflecting both additional purchases and stock price changes.
Core Scientific, Inc. (NASDAQ: CORZ - Get Free Report) saw some unusual options trading activity on Friday. Investors acquired 239,017 call options on the company. This represents an increase of approximately 87% compared to the average volume of 127,636 call options. Institutional Inflows and Outflows Institutional investors have recently made changes to their positions in the